S. Dittrich, B. T. Tadesse, F. Moussy, A. Chua, A. Zorzet et al., Target Product Profile for a Diagnostic Assay to Differentiate between Bacterial and Non-Bacterial Infections and Reduce Antimicrobial Overuse in Resource-Limited Settings: An Expert Consensus, PLOS ONE, vol.11, issue.8, 2016.

P. Hausfater, S. Garric, S. B. Ayed, M. Rosenheim, M. Bernard et al., Usefulness of Procalcitonin as a Marker of Systemic Infection in Emergency Department Patients: A Prospective Study, Clinical Infectious Diseases, vol.34, issue.7, pp.895-901, 2002.

C. L. Ventola, The Antibiotic Resistance Crisis. Pharmacy and Therapeutics, vol.40, pp.277-283, 2015.

J. G. Bartlett, D. N. Gilbert, and B. Spellberg, Seven Ways to Preserve the Miracle of Antibiotics, Clinical Infectious Diseases, vol.56, issue.10, pp.1445-1450, 2013.

K. Oved, A. Cohen, O. Boico, R. Navon, T. Friedman et al.,

E. Eden, A Novel Host-Proteome Signature for Distinguishing between Acute Bacterial and Viral Infections, PLOS ONE, vol.10, issue.3, p.120012, 2015.

I. Srugo, A. Klein, M. Stein, O. Golan-shany, N. Kerem et al.,

A. Gervaix, Validation of a Novel Assay to Distinguish Bacterial and Viral Infections, Pediatrics, vol.140, issue.4, 2017.

R. Laxminarayan, A. Duse, C. Wattal, A. K. Zaidi, H. F. Wertheim et al., Antibiotic resistance-the need for global solutions. The Lancet Infectious Diseases, vol.13, pp.1057-1098, 2013.

G. Parrott, T. Kinjo, D. Nabeya, A. Uehara, S. Nahar et al.,

J. Fujita, Evaluation of Anyplex TM II RV16 and RB5 real-time RT-PCR compared to Seeplex ® RV15 OneStep ACE and PneumoBacter ACE for the simultaneous detection of upper respiratory pathogens, Journal of Infection and Chemotherapy, vol.23, issue.12, pp.859-861, 2017.

U. Hassan, T. Ghonge, B. Reddy, M. Patel, M. Rappleye et al., A point-of-care microfluidic biochip for quantification of CD64 expression from whole blood for sepsis stratification, Nature Communications, vol.8, p.15949, 2017.

C. B. Van-houten, J. A. De-groot, A. Klein, I. Srugo, I. Chistyakov et al.,

L. J. Bont, A host-protein based assay to differentiate between bacterial and viral infections in preschool children (OPPORTUNITY): a double-blind, multicentre, validation study. The Lancet Infectious Diseases, vol.17, pp.30519-30528, 2017.

P. Chalupa, O. Beran, H. Herwald, N. Kaspr?i?kova?, and M. Holub, Evaluation of potential biomarkers for the discrimination of bacterial and viral infections, Infection, vol.39, issue.5, pp.411-417, 2011.

A. L. Vijayan, . Vanimaya, S. Ravindran, R. Saikant, S. Lakshmi et al., Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy, Journal of Intensive Care, vol.5, issue.1, 2017.

S. Gibot, M. C. Béné, R. Noel, F. Massin, J. Guy et al., Combination Biomarkers to Diagnose Sepsis in the Critically Ill Patient, American Journal of Respiratory and Critical Care Medicine, vol.186, issue.1, pp.65-71, 2012.

A. Group, E. Cuquemelle, F. Soulis, D. Villers, F. Roche-campo et al., Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study, Intensive Care Medicine, vol.37, issue.5, pp.796-800, 2011.

R. Pfister, M. Kochanek, T. Leygeber, C. Brun-buisson, E. Cuquemelle et al., Procalcitonin for diagnosis of bacterial pneumonia in critically ill patients during 2009 H1N1 influenza pandemic: a prospective cohort study, systematic review and individual patient data meta-analysis, Critical Care, vol.18, issue.2, 2014.

J. Nuutila, P. Jalava-karvinen, U. Hohenthal, P. Kotilainen, T. Pelliniemi et al., A rapid flow cytometric method for distinguishing between febrile bacterial and viral infections, Journal of Microbiological Methods, vol.92, issue.1, pp.64-72, 2013.

J. P. Haran, F. L. Beaudoin, S. Suner, and S. Lu, C-reactive protein as predictor of bacterial infection among patients with an influenza-like illness, The American Journal of Emergency Medicine, vol.31, issue.1, pp.137-144, 2013.

R. Sklavou, K. Karavanaki, E. Critselis, L. Kossiva, M. Giannaki et al.,

S. Polychronopoulou, Variation of serum C-reactive protein (CRP) over time in pediatric cancer patients with febrile illness and its relevance to identified pathogen, Clinical Biochemistry, vol.45, issue.15, pp.1178-1182, 2012.

J. Weh, C. Antoni, C. Weiß, P. Findeisen, M. Ebert et al., Discriminatory potential of C-reactive protein, cytokines, and fecal markers in infectious gastroenteritis in adults, Diagnostic Microbiology and Infectious Disease, vol.77, issue.1, pp.79-84, 2013.

J. Siegel-itzkocich, Israeli product that pinpoints viruses, bacteria gets European grant. Healt&Science-Jerusalem Post, 2016.

J. Markic, A. Jeroncic, D. Polancec, N. Bosnjak, A. Markotic et al., CD15s is a potential biomarker of serious bacterial infection in infants admitted to hospital, European Journal of Pediatrics, vol.172, issue.10, pp.1363-1369, 2013.

M. Meisner, Update on Procalcitonin Measurements, Annals of Laboratory Medicine, vol.34, issue.4, pp.263-273, 2014.

A. J. Kapasi, S. Dittrich, I. J. Gonza?lez, and T. C. Rodwell, Host Biomarkers for Distinguishing Bacterial from Non-Bacterial Causes of Acute Febrile Illness: A Comprehensive Review, PLOS ONE, vol.11, issue.8, 2016.

V. L. Pinto, IL-6 and IL-8 in cerebrospinal fluid from patients with aseptic meningitis and bacterial meningitis: their potential role as a marker for differential diagnosis, The Brazilian Journal of Infectious Diseases, p.3, 2011.

W. H. Self, J. Rosen, S. C. Sharp, M. R. Filbin, P. C. Hou et al., Diagnostic Accuracy of FebriDx: A Rapid Test to Detect Immune Responses to Viral and Bacterial Upper Respiratory Infections, Journal of Clinical Medicine, vol.6, issue.10, p.94, 2017.

I. Engelmann, F. Dubos, P. Lobert, C. Houssin, V. Degas et al., Diagnosis of Viral Infections Using Myxovirus Resistance Protein A (MxA), 2015.

, PEDIATRICS, vol.135, issue.4, pp.985-993

P. Venge, Human neutrophil lipocalin (HNL) as a biomarker of acute infections, Upsala Journal of Medical Sciences, vol.123, issue.1, pp.1-8, 2018.

P. Venge, L. Douhan-ha?kansson, D. Garwicz, C. Peterson, S. Xu et al., Human Neutrophil Lipocalin as a Superior Diagnostic Means To Distinguish between Acute Bacterial and Viral Infections, Clinical and Vaccine Immunology : CVI, vol.22, issue.9, pp.1025-1032, 2015.

S. Katoh, M. Ikeda, H. Shimizu, K. Mouri, Y. Obase et al.,

M. Oka, Increased Levels of Plasma Galectin-9 in Patients with Influenza Virus Infection, The Tohoku Journal of Experimental Medicine, vol.232, issue.4, pp.263-267, 2014.

J. Nuutila, P. Jalava-karvinen, U. Hohenthal, P. Kotilainen, T. Pelliniemi et al., Use of complement regulators, CD35, CD46, CD55, and CD59, on leukocytes as markers for diagnosis of viral and bacterial infections, Human Immunology, vol.74, issue.5, pp.522-530, 2013.

S. Mokuda, O. Doi, and K. Takasugi, Simultaneous quantitative analysis of the expression of CD64 and CD35 on neutrophils as markers to differentiate between bacterial and viral infections in patients with rheumatoid arthritis, Modern Rheumatology, vol.22, issue.5, pp.750-757, 2012.

J. Cid, R. Aguinaco, R. Sa?nchez, G. Garci?a-pardo, and A. Llorente, Neutrophil CD64 expression as marker of bacterial infection: A systematic review and meta-analysis, Journal of Infection, vol.60, issue.5, pp.313-319, 2010.

S. Li, X. Huang, Z. Chen, H. Zhong, Q. Peng et al., Neutrophil CD64 expression as a biomarker in the early diagnosis of bacterial infection: a metaanalysis, International Journal of Infectious Diseases, vol.17, issue.1, pp.12-23, 2013.

N. Xu, J. Chen, X. Chang, J. Zhang, Q. Liu et al., nCD64 index as a prognostic biomarker for mortality in acute exacerbation of chronic obstructive pulmonary disease, Annals of Saudi Medicine, vol.36, issue.1, pp.37-41, 2016.

S. Xiong, L. Pu, H. Wang, L. Hu, Y. Ding et al., Neutrophil CD64 Index as a superior biomarker for early diagnosis of infection in febrile patients in the hematology department, Clinical Chemistry and Laboratory Medicine, issue.1, p.55, 2017.

D. N. Gilbert, Role of Procalcitonin in the Management of Infected Patients in the Intensive Care Unit, Infectious Disease Clinics of North America, vol.31, issue.3, pp.435-453, 2017.

A. C. Van-der-kuyl, R. Van-den-burg, F. Zorgdrager, F. Groot, B. Berkhout et al., Sialoadhesin (CD169) Expression in CD14+ Cells Is Upregulated Early after HIV-1 Infection and Increases during Disease Progression, PLoS ONE, vol.2, issue.2, p.257, 2007.

W. Kim, C. M. Mcgary, G. E. Holder, A. R. Filipowicz, M. M. Kim et al., Increased Expression of CD169 on Blood Monocytes and Its Regulation by Virus and CD8 T Cells in Macaque Models of HIV Infection and AIDS, AIDS Research and Human Retroviruses, issue.7, pp.696-706, 2015.

H. Rempel, C. Calosing, B. Sun, and L. Pulliam, Sialoadhesin Expressed on IFNInduced Monocytes Binds HIV-1 and Enhances Infectivity, PLoS ONE, vol.3, issue.4, 2008.

M. Pino, I. Erkizia, S. Benet, E. Erikson, M. T. Ferna?ndez-figueras et al., HIV-1 immune activation induces Siglec-1 expression and enhances viral trans-infection in blood and tissue myeloid cells, Retrovirology, issue.1, p.12, 2015.

, Abréviations : CRP : proteine C-réactive

, PCT : procalcitonine. GB : Globules blancs. PNN : Polynucléaires neutrophiles. MFI : Moyenne d'intensité de fluorescence

, APHM : Assistance Publique des Hopitaux de Marseille, p.52

. Serment-d'hippocrate, Au moment d'être admis(e) à exercer la médecine, je promets et je jure d'être fidèle aux lois de l'honneur et de la probité?.probité?. Mon premier souci sera de rétablir, de préserver ou de promouvoir la santé dans tous ses éléments, physiques et mentaux

, Je respecterai toutes les personnes, leur autonomie et leur volonté?,volonté?, sans aucune discrimina on selon leur état ou leurs convictions. J'interviendrai pour les protéger si elles sont affaiblies, vulnérables ou menacées dans leur intégritéóu leur dignité?.dignité?. Même sous la contrainte, je ne ferai pas usage de mes connaissances contre les lois de l'humanité?.humanité?. J'informerai les patients des décisions envisagées

, Je ne tromperai jamais leur confiance et n'exploiterai pas le pouvoir hérité des circonstances pour forcer les consciences

, Je donnerai mes soins à l'indigent et à quiconque me les demandera. Je ne me laisserai pas influencer par la soif du gain ou la recherche de la gloire

, Reçu(e) à l'intérieur des maisons, je respecterai les secrets des foyers et ma conduite ne servira pas à corrompre les moeurs

, Je ferai tout pour soulager les souffrances. Je ne prolongerai pas abusivement les agonies. Je ne provoquerai jamais la mort délibérément

, Je n'entreprendrai rien qui dépasse mes compétences. Je les entretiendrai et les perfectionnerai pour assurer au mieux les services qui me seront demandés

, J'apporterai mon aide à mes confrères ainsi qu'à leurs familles dans l'adversité?.adversité?

, Que les hommes et mes confrères m'accordent leur estime si je suis fidèle à mes promesses